Genetic interaction networks in cancer cells.

The genotype-to-phenotype relationship in health and disease is complex and influenced by both an individual's environment and their unique genome. Personal genetic variants can modulate gene function to generate a phenotype either through a single gene effect or through genetic interactions involving two or more genes. The relevance of genetic interactions to disease phenotypes has been particularly clear in cancer research, where an extreme genetic interaction, synthetic lethality, has been exploited as a therapeutic strategy. The obvious benefits of unmasking genetic background-specific vulnerabilities, coupled with the power of systematic genome editing, have fueled efforts to translate genetic interaction mapping from model organisms to human cells. Here, we review recent developments in genetic interaction mapping, with a focus on CRISPR-based genome editing technologies and cancer.

[1]  Hans Clevers,et al.  Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors , 2016, Nature Medicine.

[2]  Thomas M. Norman,et al.  A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response , 2016, Cell.

[3]  Maximilian Billmann,et al.  Widespread Rewiring of Genetic Networks upon Cancer Signaling Pathway Activation , 2017, Cell systems.

[4]  Amalio Telenti,et al.  Human gene essentiality , 2017, Nature Reviews Genetics.

[5]  Attila Balint,et al.  Systematic analysis of complex genetic interactions , 2018, Science.

[6]  Gaelen T. Hess,et al.  Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens , 2017, Nature Communications.

[7]  D. Morgens,et al.  Systematic comparison of CRISPR-Cas9 and RNAi screens for essential genes , 2016, Nature Biotechnology.

[8]  G. Superti-Furga,et al.  Gene essentiality and synthetic lethality in haploid human cells , 2015, Science.

[9]  Adam P. Rosebrock,et al.  A global genetic interaction network maps a wiring diagram of cellular function , 2016, Science.

[10]  Norman Pavelka,et al.  Emerging and evolving concepts in gene essentiality , 2017, Nature Reviews Genetics.

[11]  Mazhar Adli,et al.  The CRISPR tool kit for genome editing and beyond , 2018, Nature Communications.

[12]  Gaelen T. Hess,et al.  Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions , 2017, Nature Biotechnology.

[13]  T. Golub,et al.  Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. , 2016, Cancer discovery.

[14]  Steven J. M. Jones,et al.  Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.

[15]  Neal K. Bennett,et al.  Mapping the Genetic Landscape of Human Cells , 2018, Cell.

[16]  Jacob D. Jaffe,et al.  Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers. , 2016, Cell systems.

[17]  Aviad Tsherniak,et al.  Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration , 2018, Nature Communications.

[18]  Thomas Hielscher,et al.  Toward an integrated map of genetic interactions in cancer cells , 2017, bioRxiv.

[19]  Christopher W Murray,et al.  Towards quantitative and multiplexed in vivo functional cancer genomics , 2018, Nature Reviews Genetics.

[20]  Scott E. Martin,et al.  Reproducible pharmacogenomic profiling of cancer cell line panels , 2016, Nature.

[21]  L. Hartwell,et al.  Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.

[22]  Antoine de Weck,et al.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening , 2017, Cell.

[23]  C. Myers,et al.  Pathway-based discovery of genetic interactions in breast cancer , 2017, PLoS genetics.

[24]  Iwei Yeh,et al.  Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma , 2018, Science.

[25]  Trey Ideker,et al.  Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls. , 2018, Journal of molecular biology.

[26]  Lei S. Qi,et al.  Genetic interaction mapping in mammalian cells using CRISPR interference , 2017, Nature Methods.

[27]  Trey Ideker,et al.  A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. , 2016, Molecular cell.

[28]  Aviad Tsherniak,et al.  Interrogation of Mammalian Protein Complex Structure, Function, and Membership Using Genome-Scale Fitness Screens. , 2018, Cell systems.

[29]  Lucas Pelkmans,et al.  Large‐scale image‐based profiling of single‐cell phenotypes in arrayed CRISPR‐Cas9 gene perturbation screens , 2018, Molecular systems biology.

[30]  R. Nitsch,et al.  CRISPR-UMI: single-cell lineage tracing of pooled CRISPR–Cas9 screens , 2017, Nature Methods.

[31]  Evan O. Paull,et al.  Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer , 2016, Cell.

[32]  Mojca Mattiazzi Usaj,et al.  Exploring genetic suppression interactions on a global scale , 2016, Science.

[33]  Eun Sug Park,et al.  Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens , 2018, Cell.

[34]  Timothy K Lu,et al.  Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM , 2016, Proceedings of the National Academy of Sciences.

[35]  E. M. DeGennaro,et al.  Multiplex gene editing by CRISPR-Cpf1 through autonomous processing of a single crRNA array , 2016, Nature Biotechnology.

[36]  Eiru Kim,et al.  Hierarchical organization of the human cell from a cancer coessentiality network , 2018, bioRxiv.

[37]  R. DePinho,et al.  Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer , 2017, Nature.

[38]  Kendall R. Sanson,et al.  Orthologous CRISPR-Cas9 enzymes for Combinatorial Genetic Screens , 2017, Nature Biotechnology.

[39]  Roded Sharan,et al.  Using deep learning to model the hierarchical structure and function of a cell , 2018, Nature Methods.

[40]  Maximilian Billmann,et al.  Integrating genetic and protein-protein interaction networks maps a functional wiring diagram of a cell. , 2018, Current opinion in microbiology.

[41]  Huimin Bian,et al.  Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene. , 2018, Cancer discovery.

[42]  M. Boutros,et al.  Time-resolved mapping of genetic interactions to model rewiring of signaling pathways , 2018, bioRxiv.

[43]  M. Raaben,et al.  Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling , 2017, Nature.

[44]  Colm J. Ryan,et al.  Synthetic Lethality and Cancer - Penetrance as the Major Barrier. , 2018, Trends in cancer.

[45]  C. Lareau,et al.  A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation , 2018, Nature Cell Biology.

[46]  Michael T. McManus,et al.  Dual gene activation and knockout screen reveals directional dependencies in genetic networks , 2018, Nature Biotechnology.

[47]  A. Ashworth,et al.  Synthetic lethal therapies for cancer: what’s next after PARP inhibitors? , 2018, Nature Reviews Clinical Oncology.

[48]  S. Orkin,et al.  Transcription control by the ENL YEATS domain in acute leukemia , 2016, Nature.

[49]  Benjamin Haibe-Kains,et al.  Inconsistency in large pharmacogenomic studies , 2013, Nature.

[50]  Ben Lehner,et al.  Pairwise and higher order genetic interactions during the evolution of a tRNA , 2018, Nature.

[51]  R. Bernards,et al.  CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes , 2016, Nature Biotechnology.

[52]  Ben Lehner,et al.  The genetic landscape of a physical interaction , 2018, eLife.

[53]  Joshua M. Korn,et al.  CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. , 2016, Cancer discovery.

[54]  Roland Arnold,et al.  A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities , 2013, Molecular systems biology.

[55]  P. Hieter,et al.  Synthetic lethality and cancer , 2017, Nature Reviews Genetics.

[56]  J. Pritchard,et al.  High‐resolution mapping of cancer cell networks using co‐functional interactions , 2018, bioRxiv.

[57]  Aaron N. Chang,et al.  Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions , 2017, Nature Methods.

[58]  Paul C. Blainey,et al.  Pooled optical screens in human cells , 2018, bioRxiv.

[59]  Qikai Xu,et al.  Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns , 2018, Cell.

[60]  D. Root,et al.  Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival. , 2018, Cancer discovery.

[61]  Yolanda T. Chong,et al.  Automated analysis of high‐content microscopy data with deep learning , 2017, Molecular systems biology.

[62]  Ann E. Sizemore,et al.  Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells , 2017, Nature Genetics.